BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weyand CM, Berry GJ, Goronzy JJ. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol 2018;103:565-75. [PMID: 28848042 DOI: 10.1189/jlb.3MA0717-283] [Cited by in Crossref: 17] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Xu M, Yu Y, Chen Y, Weng X, Zhu L. PD-1 Alleviates Cisplatin-Induced Muscle Atrophy by Regulating Inflammation and Oxidative Stress. Antioxidants (Basel) 2022;11:1839. [PMID: 36139912 DOI: 10.3390/antiox11091839] [Reference Citation Analysis]
2 Gan L, Liu D, Ma Y, Chen X, Dai A, Zhao S, Jin X, Gu G. Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges. Front Pharmacol 2022;13:962596. [DOI: 10.3389/fphar.2022.962596] [Reference Citation Analysis]
3 Arnold S, Klapa S, Holl-Ulrich K, Müller A, Kerstein-Stähle A, Lamprecht P. [Granulomatous vasculitides and vasculitides with extravascular granulomatosis]. Z Rheumatol 2022. [PMID: 35962194 DOI: 10.1007/s00393-022-01249-7] [Reference Citation Analysis]
4 Pan W, Yin L, Guo Y, Pan D, Huang H. Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma. Front Pharmacol 2022;13:890546. [DOI: 10.3389/fphar.2022.890546] [Reference Citation Analysis]
5 Les I, Pérez-Francisco I, Cabero M, Sánchez C, Hidalgo M, Teijeira L, Arrazubi V, Domínguez S, Anaut P, Eguiluz S, Elejalde I, Herrera A, Martínez M. Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study. Front Pharmacol 2022;13:894550. [PMID: 35721217 DOI: 10.3389/fphar.2022.894550] [Reference Citation Analysis]
6 Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, Grayson PC, McAdoo SP, Mason JC, Owen C, Weyand CM, Youngstein T, Dhaun N. Large-vessel vasculitis. Nat Rev Dis Primers 2022;7:93. [PMID: 34992251 DOI: 10.1038/s41572-021-00327-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Ni J, Zhou Y, Wang S, Guo T, Hu J, Chu Q, Yang X, Chu L, Chu X, Li Y, Zhu Z. A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer. Cancer Immunol Immunother 2021. [PMID: 34613418 DOI: 10.1007/s00262-021-03070-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li HY, Xu JN, Shuai ZW. Cellular signaling pathways of T cells in giant cell arteritis. J Geriatr Cardiol 2021;18:768-78. [PMID: 34659383 DOI: 10.11909/j.issn.1671-5411.2021.09.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Vos AG, Dodd CN, Delemarre EM, Nierkens S, Serenata C, Grobbee DE, Klipstein-Grobusch K, Venter WDF. Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk. Front Immunol 2021;12:647805. [PMID: 34290695 DOI: 10.3389/fimmu.2021.647805] [Reference Citation Analysis]
10 Li SY, Yoshida Y, Kobayashi E, Kubota M, Matsutani T, Mine S, Machida T, Maezawa Y, Takemoto M, Yokote K, Kobayashi Y, Takizawa H, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kobayashi S, Matsushita K, Nomura F, Matsubara H, Sumazaki M, Ito M, Yajima S, Shimada H, Iwase K, Ashino H, Wang H, Goto K, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y, Hiwasa T. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis. Sci Rep 2021;11:13450. [PMID: 34188129 DOI: 10.1038/s41598-021-92786-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Bobircă A, Bobircă F, Ancuta I, Florescu A, Pădureanu V, Florescu DN, Pădureanu R, Florescu A, Mușetescu AE. Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy. Biology (Basel) 2021;10:561. [PMID: 34203101 DOI: 10.3390/biology10060561] [Reference Citation Analysis]
12 Zeisbrich M, Chevalier N, Sehnert B, Rizzi M, Venhoff N, Thiel J, Voll RE. CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1. Front Immunol 2021;12:673912. [PMID: 34108971 DOI: 10.3389/fimmu.2021.673912] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
14 Han H, Du R, Cheng P, Zhang J, Chen Y, Li G. Comprehensive Analysis of the Immune Infiltrates and Aberrant Pathways Activation in Atherosclerotic Plaque. Front Cardiovasc Med 2020;7:602345. [PMID: 33614738 DOI: 10.3389/fcvm.2020.602345] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Liu Y, Liu N, Liu Q. Constructing a ceRNA-immunoregulatory network associated with the development and prognosis of human atherosclerosis through weighted gene co-expression network analysis. Aging (Albany NY) 2021;13:3080-100. [PMID: 33460396 DOI: 10.18632/aging.202486] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Veluswamy P, Wacker M, Scherner M, Wippermann J. Delicate Role of PD-L1/PD-1 Axis in Blood Vessel Inflammatory Diseases: Current Insight and Future Significance. Int J Mol Sci 2020;21:E8159. [PMID: 33142805 DOI: 10.3390/ijms21218159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Sun L, Zhang W, Zhao Y, Wang F, Liu S, Liu L, Zhao L, Lu W, Li M, Xu Y. Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead. Front Immunol 2020;11:1456. [PMID: 32849502 DOI: 10.3389/fimmu.2020.01456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lamberti G, Gelsomino F, Brocchi S, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C, Fiorentino M, Ardizzoni A. New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event. Ther Adv Med Oncol 2020;12:1758835920913801. [PMID: 32782484 DOI: 10.1177/1758835920913801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Manzo C, Milchert M, Natale M, Brzosko M. Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward? Reumatologia 2020;58:184-6. [PMID: 32684653 DOI: 10.5114/reum.2020.96549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Liu L, Hou J, Xu Y, Qin L, Liu W, Zhang H, Li Y, Chen M, Deng M, Zhao B, Hu J, Zheng H, Li C, Meng S. PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response. PLoS One 2020;15:e0228302. [PMID: 32628668 DOI: 10.1371/journal.pone.0228302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
21 Stamatis P. Giant Cell Arteritis versus Takayasu Arteritis: An Update. Mediterr J Rheumatol 2020;31:174-82. [PMID: 32676554 DOI: 10.31138/mjr.31.2.174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Melissaropoulos K, Klavdianou K, Filippopoulou A, Kalofonou F, Kalofonos H, Daoussis D. Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors. Int J Mol Sci 2020;21:E3389. [PMID: 32403289 DOI: 10.3390/ijms21093389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
23 Han D, Dong J, Li H, Ma T, Yu W, Song L. Cardiac adverse events of PD-1 and PD-L1 inhibitors in cancer protocol for a systematic review and network meta-analysis: A protocol for systematic review. Medicine (Baltimore) 2020;99:e18701. [PMID: 32000374 DOI: 10.1097/MD.0000000000018701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Kametani Y, Ohno Y, Ohshima S, Tsuda B, Yasuda A, Seki T, Ito R, Tokuda Y. Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors. Int J Mol Sci 2019;20:E6337. [PMID: 31888191 DOI: 10.3390/ijms20246337] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
25 Weiner R, Hanson B, Rehman J, Sun B. Isolated testicular vasculitis due to immune checkpoint inhibitor. Eur J Rheumatol 2020;7:35-6. [PMID: 31782719 DOI: 10.5152/eurjrheum.2019.19061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Raftery MJ, Abdelaziz MO, Hofmann J, Schönrich G. Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism. Front Immunol 2018;9:2560. [PMID: 30559738 DOI: 10.3389/fimmu.2018.02560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
27 Oren O, Herrmann J. Arterial events in cancer patients-the case of acute coronary thrombosis. J Thorac Dis 2018;10:S4367-85. [PMID: 30701104 DOI: 10.21037/jtd.2018.12.79] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
28 Kuret T, Burja B, Feichtinger J, Thallinger GG, Frank-Bertoncelj M, Lakota K, Žigon P, Sodin-Semrl S, Čučnik S, Tomšič M, Hočevar A. Gene and miRNA expression in giant cell arteritis-a concise systematic review of significantly modified studies. Clin Rheumatol 2019;38:307-16. [PMID: 30069799 DOI: 10.1007/s10067-018-4231-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 van der Geest KSM, Sandovici M, van Sleen Y, Sanders JS, Bos NA, Abdulahad WH, Stegeman CA, Heeringa P, Rutgers A, Kallenberg CGM, Boots AMH, Brouwer E. Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis? Arthritis Rheumatol 2018;70:1366-76. [PMID: 29648680 DOI: 10.1002/art.40520] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
30 Feng L, Deng C, Li Y. Assessment of the Relationship between Carotid Intima-Media Thickening and Early-Stage Diabetic Kidney Disease Coupled with Helicobacter pylori Infection. Dis Markers 2018;2018:3793768. [PMID: 29849820 DOI: 10.1155/2018/3793768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
31 Hid Cadena R, Abdulahad WH, Hospers GAP, Wind TT, Boots AMH, Heeringa P, Brouwer E. Checks and Balances in Autoimmune Vasculitis. Front Immunol 2018;9:315. [PMID: 29520282 DOI: 10.3389/fimmu.2018.00315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]